Show
				
											10 
											20 
											30 
											40 
									 
				results per page
			 
		 
					
	Discovery of small molecules targeting SARS-CoV-2 frameshifting using a rapid yeast platform 
		
		Jan, Eric  |
		University of British Columbia  |		Project Grant  |		$445,230	
	
		CIHR 		British Columbia 		2021 	
			Read More 
	 
					
	COVID-19 Variant Supplement – Peptide macrocycle decoys against COVID‑19 viral spike protein 
		
		Perrin, David M  |
		University of British Columbia  |		Operating Grant  |		$50,000	
	
		CIHR 		British Columbia 		2021 	
			Read More 
	 
					
	Investigating access to and outcomes from supervised drug consumption services in British Columbia before and during the COVID‑19 pandemic 
		
		Kerr, Thomas H  |
		British Columbia Centre on Substance Use  |		Operating Grant  |		$249,065	
	
		CIHR 		British Columbia 		2021 	
			Read More 
	 
					
	A double blind randomized trial of low-dose naltrexone for post-covid fatigue syndrome 
		
		Nacul, Luis  |
		B.C. Women's Hospital  |		Operating Grant  |		$742,331	
	
		CIHR 		British Columbia 		2021 	
			Read More 
	 
					
	COVID-19 Variant Network – Bespoke transition state analog inhibitors of SARS-CoV-2 3CL and PL proteases 
		
		Strynadka, Natalie C  |
		University of British Columbia  |		Operating Grant  |		$100,000	
	
		CIHR 		British Columbia 		2021 	
			Read More 
	 
					
	COVID-19 Variant Supplement – The COVID‑19 Pandemic Among Sexual and Gender Marginalized Populations in Canada: Physical Distancing Impacts, SARS-CoV-2 Seroprevalence, and Health and Wellness Needs 
		
		Lachowsky, Nathan J  |
		University of Victoria  |		Operating Grant  |		$50,000	
	
		CIHR 		British Columbia 		2021 	
			Read More 
	 
					
	Investigating Neuropsychological Consequences of COVID‑19 on Adults, and Examination of Associated Risk and Resilience Factors 
		
		Paterson, Theone  |
		University of Victoria  |		Operating Grant  |		$199,121	
	
		CIHR 		British Columbia 		2021 	
			Read More 
	 
					
	COVID-19 Variant Supplement – Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID‑19 disease expression and development of therapeutics 
		
		Haas, Kurt  |
		University of British Columbia  |		Operating Grant  |		$50,000	
	
		CIHR 		British Columbia 		2021 	
			Read More 
	 
					
	All-cause and cause-specific acute morbidity attributable to Covid-19 epidemic, severe Covid-19 symptoms, and adverse birth outcomes in Canada. 
		
		Lisonkova, Sarka  |
		University of British Columbia  |		Project Grant  |		$168,300	
	
		CIHR 		British Columbia 		2021 	
			Read More 
	 
					
	An Environmental Scan of Service Adaptations in Community-Based Harm Reduction Services for Indigenous Peoples in Response to the COVID‑19 Pandemic 
		
		Masching, Renee  |
		Communities, Alliances & Networks  |		Other  |		$100,000	
	
		CIHR 		British Columbia 		2021 	
			Read More